PATENT CLAIM ANALYSIS

Application Number: 16014231
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "259300"]

Abstract:
Compounds of Formula 0, Formula I, and Formula II and methods of use as Interleukin-1 Receptor Associated Kinase (IRAK4) inhibitors are described herein.

Claim (Index 20):
The compound of  claim 1 , or a stereoisomer or pharmaceutically acceptable salt thereof, wherein the following portion of Formula 0, Formula I, or Formula II is further defined as 0-A, I-A, or II-A: wherein A is a 5 or 6 membered ring optionally containing an additional ring heteroatom and wherein A is optionally substituted by halogen, oxo, CN, OH, C 1-6 alkyl, C 3-6 cycloalkyl group, \u2014NR 8 R 9 , NR 12 C(O)R 13 , \u2014NR 12 S(O) 1-2 R 13 , \u2014C(O)NR 10 R 11 , \u2014C(O)OR 13 , or \u2014S(O) 1-2 NR 10 R 11 ,\n wherein any alkyl or cycloalkyl group is independently optionally substituted by halogen, oxo, CN, OH, C 1-3 alkyl, C 1-3 haloalkyl, C 1-3 alkoxy, or C 1-3 haloalkoxy.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 94.0
- Lexical Diversity: 1.21739
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15905524', '15305390', '15247429', '15822493', '15305372']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8213818687018876
- 35 USC 102 Novelty (BERT): 0.549850056465412
- Combined Prediction Score: 0.79422868747824
- Mean Citation Score: 404.523194
- Max Citation Score: 418.23807
- Similarity Product: 321.3876251639593

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test